In contrast the frequency of CCR4-expressing CD4+ T cells in BM was substantially increased in patients with myeloma to an average expression of 20% of the CD4+ T cell pool (**p = < 0.01). The gene discussed is CCR4; the disease is plasma cell myeloma.